Common use of Sublicense Consideration Clause in Contracts

Sublicense Consideration. Within sixty (60) days of the end of each calendar quarter during the term of this Agreement, Company will pay to University [***] of any Sublicense Consideration received by Company during such calendar quarter unless reduced by achievement of Performance Milestones by Company or its Sublicensees prior to execution of the particular Sublicense in accordance with the schedule below. Determination of the relevant Performance Milestone having been achieved for the purposes of determining the Sublicense Consideration percentage shall be based on the most advanced Licensed Product candidate then in development for which Sublicense Consideration was received. A further reduction of the percentage of Sublicense Consideration payable to University under this Agreement will be negotiated in good faith between the Parties where, in addition to the Sublicense of any rights granted to Company hereunder, Company or its Sublicensee also grants a Sublicensee a license or sublicense under a Third Party’s intellectual property rights that are or would be infringed by Licensed Product(s) (treating pending patent applications as if they were issued patents), but only to the extent that the total aggregate consideration for such combined license is treated as Sublicense Consideration. Milestone Has Been Achieved at the Date of Execution of the Sublicense Sublicense Consideration Percentage A3.2.1 Performance Milestone 1 [***]

Appears in 2 contracts

Samples: License and Exclusive Option Agreement (Icosavax, Inc.), License and Exclusive Option Agreement (Icosavax, Inc.)

AutoNDA by SimpleDocs

Sublicense Consideration. Within sixty (60) days of the end of each calendar quarter during the term of this Agreement, Company will pay to University [***] of any Sublicense Consideration received by Company during such calendar quarter unless reduced by achievement of Performance Milestones by Company or its Sublicensees prior to execution of the particular Sublicense in accordance with the schedule below. Determination of the relevant Performance Milestone having been achieved for the purposes of determining the Sublicense Consideration percentage shall be based on the most advanced Licensed Product candidate then in development in the applicable Indication Category for which Sublicense Consideration was received. A further reduction of the percentage of Sublicense Consideration payable to University under this Agreement will be negotiated in good faith between the Parties where, in addition to the Sublicense of any Icosavax, Inc. / University of Washington Exclusive License Agreement UW CoMotion Ref. [***] rights granted to Company hereunder, Company or its Sublicensee also grants a Sublicensee a license or sublicense under a Third Party’s intellectual property rights that are or would be infringed by Licensed Product(s) (treating pending patent applications as if they were issued patents), but only to the extent that the total aggregate consideration for such combined license is treated as Sublicense Consideration. Performance Milestone Has Been Achieved at the Date of Execution of the Sublicense related to the applicable Indication Category Sublicense Consideration Percentage A3.2.1 Performance Milestone 1 [***]Percentage

Appears in 2 contracts

Samples: Exclusive License Agreement (Icosavax, Inc.), Exclusive License Agreement (Icosavax, Inc.)

AutoNDA by SimpleDocs

Sublicense Consideration. Within sixty (60) days of the end of each calendar quarter during the term of this Agreement, Company will pay to University [***] of any Sublicense Consideration received by Company during such calendar quarter unless reduced by achievement of Performance Milestones by Company or its Sublicensees prior to execution of the particular Sublicense in accordance with the schedule below. Determination of the relevant Performance Milestone having been achieved for the purposes of determining the Sublicense Consideration percentage shall be based on the most advanced Licensed Product candidate then [***] (without regard to whether [***]). For clarity, if Company also grants a Sublicensee a sublicense under any of the Other License Agreements, Company will not be required to pay to University under this Agreement and/or such Other License Agreements an aggregate amount in development for which excess of the percentage of the Sublicense Consideration was receivedset forth in this Agreement. A further reduction of the percentage of Sublicense Consideration payable to University under this Agreement will be negotiated in good faith between the Parties where, in addition to the Sublicense of any rights granted to Company hereunder, Company or its Sublicensee also grants a Sublicensee a license or sublicense under a Third Party’s intellectual property rights that are or would be infringed by Licensed Product(s) (treating pending patent applications as if they were issued patents), but only to the extent that the total aggregate consideration for such combined license is treated as Sublicense Consideration. Performance Milestone of the Most Advanced Licensed Product that Has Been Achieved at the Date of Execution of the Sublicense Sublicense Consideration Percentage A3.2.1 Performance Milestone 1 [***]Percentage

Appears in 1 contract

Samples: Exclusive License Agreement (Icosavax, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.